Project

EORTC 1901-LCG PRIMALung Study

Scheduled · 2022 until 2030

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Scheduled
Start Date
2022
End Date
2030
Financing
Others
Study Design
This is an academic-led, open-label, multicentre, randomized phase III trial.
Labels
lung cancer
Brief description/objective

PRophylactic cerebral Irradiation or active MAgnetic resonance imaging surveillance in small-cell Lung cancer patients (PRIMALung study)